Global Devices for Inhaled Medications Market Insights and Forecast to 2026

1.1 Devices for Inhaled Medications Product Introduction

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered: Ranking of Global Top Devices for Inhaled Medications Manufacturers by Revenue in 2019

1.4 Market by Type

1.4.1 Global Devices for Inhaled Medications Market Size Growth Rate by Type

1.4.2 Dry Powder Inhalers

1.4.3 Metered-Dose Inhalers

1.4.4 Nebulizers

1.4.5 Soft Mist Inhaler

1.5 Market by Application

1.5.1 Global Devices for Inhaled Medications Market Size Growth Rate by Application

1.5.2 Clinic

1.5.3 Hospital

1.5.4 Home

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Devices for Inhaled Medications Market Size, Estimates and Forecasts

2.1.1 Global Devices for Inhaled Medications Revenue Estimates and Forecasts 2015-2026

2.1.2 Global Devices for Inhaled Medications Production Capacity Estimates and Forecasts 2015-2026

2.1.3 Global Devices for Inhaled Medications Production Estimates and Forecasts 2015-2026

2.2 Global Devices for Inhaled Medications, Market Size by Producing Regions: 2015 VS 2020 VS 2026

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.3.3 Global Devices for Inhaled Medications Manufacturers Geographical Distribution

2.4 Key Trends for Devices for Inhaled Medications Markets & Products

2.5 Primary Interviews with Key Devices for Inhaled Medications Players (Opinion Leaders)

3 Market Size by Manufacturers

3.1 Global Top Devices for Inhaled Medications Manufacturers by Production Capacity

3.1.1 Global Top Devices for Inhaled Medications Manufacturers by Production Capacity (2015-2020)

3.1.2 Global Top Devices for Inhaled Medications Manufacturers by Production (2015-2020)

3.1.3 Global Top Devices for Inhaled Medications Manufacturers Market Share by Production

3.2 Global Top Devices for Inhaled Medications Manufacturers by Revenue

3.2.1 Global Top Devices for Inhaled Medications Manufacturers by Revenue (2015-2020)

3.2.2 Global Top Devices for Inhaled Medications Manufacturers Market Share by Revenue (2015-2020)

3.2.3 Global Top 10 and Top 5 Companies by Devices for Inhaled Medications Revenue in 2019

3.3 Global Devices for Inhaled Medications Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

4 Devices for Inhaled Medications Production by Regions

4.1 Global Devices for Inhaled Medications Historic Market Facts & Figures by Regions

4.1.1 Global Top Devices for Inhaled Medications Regions by Production (2015-2020)

4.1.2 Global Top Devices for Inhaled Medications Regions by Revenue (2015-2020)

4.2 North America

4.2.1 North America Devices for Inhaled Medications Production (2015-2020)

4.2.2 North America Devices for Inhaled Medications Revenue (2015-2020)

4.2.3 Key Players in North America

4.2.4 North America Devices for Inhaled Medications Import & Export (2015-2020)

4.3 Europe

4.3.1 Europe Devices for Inhaled Medications Production (2015-2020)

4.3.2 Europe Devices for Inhaled Medications Revenue (2015-2020)

4.3.3 Key Players in Europe

4.3.4 Europe Devices for Inhaled Medications Import & Export (2015-2020)

4.4 China

4.4.1 China Devices for Inhaled Medications Production (2015-2020)

4.4.2 China Devices for Inhaled Medications Revenue (2015-2020)

4.4.3 Key Players in China

4.4.4 China Devices for Inhaled Medications Import & Export (2015-2020)

4.5 Japan

4.5.1 Japan Devices for Inhaled Medications Production (2015-2020)

4.5.2 Japan Devices for Inhaled Medications Revenue (2015-2020)

4.5.3 Key Players in Japan

4.5.4 Japan Devices for Inhaled Medications Import & Export (2015-2020)

5 Devices for Inhaled Medications Consumption by Region

5.1 Global Top Devices for Inhaled Medications Regions by Consumption

5.1.1 Global Top Devices for Inhaled Medications Regions by Consumption (2015-2020)

5.1.2 Global Top Devices for Inhaled Medications Regions Market Share by Consumption (2015-2020)

5.2 North America

5.2.1 North America Devices for Inhaled Medications Consumption by Application

5.2.2 North America Devices for Inhaled Medications Consumption by Countries

5.2.3 U.S.

5.2.4 Canada

5.3 Europe

5.3.1 Europe Devices for Inhaled Medications Consumption by Application

5.3.2 Europe Devices for Inhaled Medications Consumption by Countries

5.3.3 Germany

5.3.4 France

5.3.5 U.K.

5.3.6 Italy

5.3.7 Russia

5.4 Asia Pacific

5.4.1 Asia Pacific Devices for Inhaled Medications Consumption by Application

5.4.2 Asia Pacific Devices for Inhaled Medications Consumption by Regions

5.4.3 China

5.4.4 Japan

5.4.5 South Korea

5.4.6 India

5.4.7 Australia

5.4.8 Taiwan

5.4.9 Indonesia

5.4.10 Thailand

5.4.11 Malaysia

5.4.12 Philippines

5.4.13 Vietnam

5.5 Central & South America

5.5.1 Central & South America Devices for Inhaled Medications Consumption by Application

5.5.2 Central & South America Devices for Inhaled Medications Consumption by Country

5.5.3 Mexico

5.5.3 Brazil

5.5.3 Argentina

5.6 Middle East and Africa

5.6.1 Middle East and Africa Devices for Inhaled Medications Consumption by Application

5.6.2 Middle East and Africa Devices for Inhaled Medications Consumption by Countries

5.6.3 Turkey

5.6.4 Saudi Arabia

5.6.5 U.A.E

6 Market Size by Type (2015-2026)

6.1 Global Devices for Inhaled Medications Market Size by Type (2015-2020)

6.1.1 Global Devices for Inhaled Medications Production by Type (2015-2020)

6.1.2 Global Devices for Inhaled Medications Revenue by Type (2015-2020)

6.1.3 Devices for Inhaled Medications Price by Type (2015-2020)

6.2 Global Devices for Inhaled Medications Market Forecast by Type (2021-2026)

6.2.1 Global Devices for Inhaled Medications Production Forecast by Type (2021-2026)

6.2.2 Global Devices for Inhaled Medications Revenue Forecast by Type (2021-2026)

6.2.3 Global Devices for Inhaled Medications Price Forecast by Type (2021-2026)

6.3 Global Devices for Inhaled Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

7.2.1 Global Devices for Inhaled Medications Consumption Historic Breakdown by Application (2015-2020)

7.2.2 Global Devices for Inhaled Medications Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

8.1 Consort Medical

8.1.1 Consort Medical Corporation Information

8.1.2 Consort Medical Overview

8.1.3 Consort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.1.4 Consort Medical Product Description

8.1.5 Consort Medical Related Developments

8.2 Inhalexper

8.2.1 Inhalexper Corporation Information

8.2.2 Inhalexper Overview

8.2.3 Inhalexper Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.2.4 Inhalexper Product Description

8.2.5 Inhalexper Related Developments

8.3 Cambridge Consultants

8.3.1 Cambridge Consultants Corporation Information

8.3.2 Cambridge Consultants Overview

8.3.3 Cambridge Consultants Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.3.4 Cambridge Consultants Product Description

8.3.5 Cambridge Consultants Related Developments

8.4 Hovione

8.4.1 Hovione Corporation Information

8.4.2 Hovione Overview

8.4.3 Hovione Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.4.4 Hovione Product Description

8.4.5 Hovione Related Developments

8.5 Catalent, Inc

8.5.1 Catalent, Inc Corporation Information

8.5.2 Catalent, Inc Overview

8.5.3 Catalent, Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.5.4 Catalent, Inc Product Description

8.5.5 Catalent, Inc Related Developments

8.6 VertMarkets, Inc

8.6.1 VertMarkets, Inc Corporation Information

8.6.2 VertMarkets, Inc Overview

8.6.3 VertMarkets, Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.6.4 VertMarkets, Inc Product Description

8.6.5 VertMarkets, Inc Related Developments

8.7 Qualicaps

8.7.1 Qualicaps Corporation Information

8.7.2 Qualicaps Overview

8.7.3 Qualicaps Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.7.4 Qualicaps Product Description

8.7.5 Qualicaps Related Developments

8.8 3M

8.8.1 3M Corporation Information

8.8.2 3M Overview

8.8.3 3M Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.8.4 3M Product Description

8.8.5 3M Related Developments

8.9 Aerovance

8.9.1 Aerovance Corporation Information

8.9.2 Aerovance Overview

8.9.3 Aerovance Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.9.4 Aerovance Product Description

8.9.5 Aerovance Related Developments

8.10 AstraZeneca

8.10.1 AstraZeneca Corporation Information

8.10.2 AstraZeneca Overview

8.10.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.10.4 AstraZeneca Product Description

8.10.5 AstraZeneca Related Developments

8.11 Boehringer Ingelheim

8.11.1 Boehringer Ingelheim Corporation Information

8.11.2 Boehringer Ingelheim Overview

8.11.3 Boehringer Ingelheim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.11.4 Boehringer Ingelheim Product Description

8.11.5 Boehringer Ingelheim Related Developments

8.12 Chiesi

8.12.1 Chiesi Corporation Information

8.12.2 Chiesi Overview

8.12.3 Chiesi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.12.4 Chiesi Product Description

8.12.5 Chiesi Related Developments

8.13 Cipla

8.13.1 Cipla Corporation Information

8.13.2 Cipla Overview

8.13.3 Cipla Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.13.4 Cipla Product Description

8.13.5 Cipla Related Developments

8.14 Civitas/Alkermes

8.14.1 Civitas/Alkermes Corporation Information

8.14.2 Civitas/Alkermes Overview

8.14.3 Civitas/Alkermes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.14.4 Civitas/Alkermes Product Description

8.14.5 Civitas/Alkermes Related Developments

8.15 GlaxoSmithKline

8.15.1 GlaxoSmithKline Corporation Information

8.15.2 GlaxoSmithKline Overview

8.15.3 GlaxoSmithKline Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.15.4 GlaxoSmithKline Product Description

8.15.5 GlaxoSmithKline Related Developments

8.16 Hovione

8.16.1 Hovione Corporation Information

8.16.2 Hovione Overview

8.16.3 Hovione Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.16.4 Hovione Product Description

8.16.5 Hovione Related Developments

8.17 Mannkind

8.17.1 Mannkind Corporation Information

8.17.2 Mannkind Overview

8.17.3 Mannkind Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.17.4 Mannkind Product Description

8.17.5 Mannkind Related Developments

8.18 Mantecorp

8.18.1 Mantecorp Corporation Information

8.18.2 Mantecorp Overview

8.18.3 Mantecorp Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.18.4 Mantecorp Product Description

8.18.5 Mantecorp Related Developments

8.19 Meda

8.19.1 Meda Corporation Information

8.19.2 Meda Overview

8.19.3 Meda Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.19.4 Meda Product Description

8.19.5 Meda Related Developments

8.20 MicroDose Therapeutx

8.20.1 MicroDose Therapeutx Corporation Information

8.20.2 MicroDose Therapeutx Overview

8.20.3 MicroDose Therapeutx Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.20.4 MicroDose Therapeutx Product Description

8.20.5 MicroDose Therapeutx Related Developments

8.21 Novartis

8.21.1 Novartis Corporation Information

8.21.2 Novartis Overview

8.21.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.21.4 Novartis Product Description

8.21.5 Novartis Related Developments

9 Devices for Inhaled Medications Production Forecast by Regions

9.1 Global Top Devices for Inhaled Medications Regions Forecast by Revenue (2021-2026)

9.2 Global Top Devices for Inhaled Medications Regions Forecast by Production (2021-2026)

9.3 Key Devices for Inhaled Medications Production Regions Forecast

9.3.1 North America

9.3.2 Europe

9.3.3 China

9.3.4 Japan

10 Devices for Inhaled Medications Consumption Forecast by Region

10.1 Global Devices for Inhaled Medications Consumption Forecast by Region (2021-2026)

10.2 North America Devices for Inhaled Medications Consumption Forecast by Region (2021-2026)

10.3 Europe Devices for Inhaled Medications Consumption Forecast by Region (2021-2026)

10.4 Asia Pacific Devices for Inhaled Medications Consumption Forecast by Region (2021-2026)

10.5 Latin America Devices for Inhaled Medications Consumption Forecast by Region (2021-2026)

10.6 Middle East and Africa Devices for Inhaled Medications Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis

11.2 Sales Channels Analysis

11.2.1 Devices for Inhaled Medications Sales Channels

11.2.2 Devices for Inhaled Medications Distributors

11.3 Devices for Inhaled Medications Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

12.1 Devices for Inhaled Medications Industry

12.2 Market Trends

12.3 Market Opportunities and Drivers

12.4 Market Challenges

12.5 Devices for Inhaled Medications Market Risks/Restraints

12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Devices for Inhaled Medications Study

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

Table 1. Devices for Inhaled Medications Key Market Segments in This Study

Table 2. Ranking of Global Top Devices for Inhaled Medications Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Devices for Inhaled Medications Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)

Table 4. Major Manufacturers of Dry Powder Inhalers

Table 5. Major Manufacturers of Metered-Dose Inhalers

Table 6. Major Manufacturers of Nebulizers

Table 7. Major Manufacturers of Soft Mist Inhaler

Table 8. Global Devices for Inhaled Medications Market Size Growth Rate by Application 2020-2026 (K Units)

Table 9. Global Devices for Inhaled Medications Market Size by Region in US$ Million: 2015 VS 2020 VS 2026

Table 10. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 11. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Devices for Inhaled Medications as of 2019)

Table 12. Devices for Inhaled Medications Manufacturing Base Distribution and Headquarters

Table 13. Manufacturers Devices for Inhaled Medications Product Offered

Table 14. Date of Manufacturers Enter into Devices for Inhaled Medications Market

Table 15. Key Trends for Devices for Inhaled Medications Markets & Products

Table 16. Main Points Interviewed from Key Devices for Inhaled Medications Players

Table 17. Global Devices for Inhaled Medications Production Capacity by Manufacturers (2015-2020) (K Units)

Table 18. Global Devices for Inhaled Medications Production Share by Manufacturers (2015-2020)

Table 19. Devices for Inhaled Medications Revenue by Manufacturers (2015-2020) (Million US$)

Table 20. Devices for Inhaled Medications Revenue Share by Manufacturers (2015-2020)

Table 21. Devices for Inhaled Medications Price by Manufacturers 2015-2020 (USD/Unit)

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Devices for Inhaled Medications Production by Regions (2015-2020) (K Units)

Table 24. Global Devices for Inhaled Medications Production Market Share by Regions (2015-2020)

Table 25. Global Devices for Inhaled Medications Revenue by Regions (2015-2020) (US$ Million)

Table 26. Global Devices for Inhaled Medications Revenue Market Share by Regions (2015-2020)

Table 27. Key Devices for Inhaled Medications Players in North America

Table 28. Import & Export of Devices for Inhaled Medications in North America (K Units)

Table 29. Key Devices for Inhaled Medications Players in Europe

Table 30. Import & Export of Devices for Inhaled Medications in Europe (K Units)

Table 31. Key Devices for Inhaled Medications Players in China

Table 32. Import & Export of Devices for Inhaled Medications in China (K Units)

Table 33. Key Devices for Inhaled Medications Players in Japan

Table 34. Import & Export of Devices for Inhaled Medications in Japan (K Units)

Table 35. Global Devices for Inhaled Medications Consumption by Regions (2015-2020) (K Units)

Table 36. Global Devices for Inhaled Medications Consumption Market Share by Regions (2015-2020)

Table 37. North America Devices for Inhaled Medications Consumption by Application (2015-2020) (K Units)

Table 38. North America Devices for Inhaled Medications Consumption by Countries (2015-2020) (K Units)

Table 39. Europe Devices for Inhaled Medications Consumption by Application (2015-2020) (K Units)

Table 40. Europe Devices for Inhaled Medications Consumption by Countries (2015-2020) (K Units)

Table 41. Asia Pacific Devices for Inhaled Medications Consumption by Application (2015-2020) (K Units)

Table 42. Asia Pacific Devices for Inhaled Medications Consumption Market Share by Application (2015-2020) (K Units)

Table 43. Asia Pacific Devices for Inhaled Medications Consumption by Regions (2015-2020) (K Units)

Table 44. Latin America Devices for Inhaled Medications Consumption by Application (2015-2020) (K Units)

Table 45. Latin America Devices for Inhaled Medications Consumption by Countries (2015-2020) (K Units)

Table 46. Middle East and Africa Devices for Inhaled Medications Consumption by Application (2015-2020) (K Units)

Table 47. Middle East and Africa Devices for Inhaled Medications Consumption by Countries (2015-2020) (K Units)

Table 48. Global Devices for Inhaled Medications Production by Type (2015-2020) (K Units)

Table 49. Global Devices for Inhaled Medications Production Share by Type (2015-2020)

Table 50. Global Devices for Inhaled Medications Revenue by Type (2015-2020) (Million US$)

Table 51. Global Devices for Inhaled Medications Revenue Share by Type (2015-2020)

Table 52. Devices for Inhaled Medications Price by Type 2015-2020 (USD/Unit)

Table 53. Global Devices for Inhaled Medications Consumption by Application (2015-2020) (K Units)

Table 54. Global Devices for Inhaled Medications Consumption Share by Application (2015-2020)

Table 55. Consort Medical Corporation Information

Table 56. Consort Medical Description and Major Businesses

Table 57. Consort Medical Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 58. Consort Medical Product

Table 59. Consort Medical Recent Development

Table 60. Inhalexper Corporation Information

Table 61. Inhalexper Description and Major Businesses

Table 62. Inhalexper Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 63. Inhalexper Product

Table 64. Inhalexper Recent Development

Table 65. Cambridge Consultants Corporation Information

Table 66. Cambridge Consultants Description and Major Businesses

Table 67. Cambridge Consultants Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 68. Cambridge Consultants Product

Table 69. Cambridge Consultants Recent Development

Table 70. Hovione Corporation Information

Table 71. Hovione Description and Major Businesses

Table 72. Hovione Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 73. Hovione Product

Table 74. Hovione Recent Development

Table 75. Catalent, Inc Corporation Information

Table 76. Catalent, Inc Description and Major Businesses

Table 77. Catalent, Inc Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 78. Catalent, Inc Product

Table 79. Catalent, Inc Recent Development

Table 80. VertMarkets, Inc Corporation Information

Table 81. VertMarkets, Inc Description and Major Businesses

Table 82. VertMarkets, Inc Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 83. VertMarkets, Inc Product

Table 84. VertMarkets, Inc Recent Development

Table 85. Qualicaps Corporation Information

Table 86. Qualicaps Description and Major Businesses

Table 87. Qualicaps Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 88. Qualicaps Product

Table 89. Qualicaps Recent Development

Table 90. 3M Corporation Information

Table 91. 3M Description and Major Businesses

Table 92. 3M Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 93. 3M Product

Table 94. 3M Recent Development

Table 95. Aerovance Corporation Information

Table 96. Aerovance Description and Major Businesses

Table 97. Aerovance Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 98. Aerovance Product

Table 99. Aerovance Recent Development

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Major Businesses

Table 102. AstraZeneca Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 103. AstraZeneca Product

Table 104. AstraZeneca Recent Development

Table 105. Boehringer Ingelheim Corporation Information

Table 106. Boehringer Ingelheim Description and Major Businesses

Table 107. Boehringer Ingelheim Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 108. Boehringer Ingelheim Product

Table 109. Boehringer Ingelheim Recent Development

Table 110. Chiesi Corporation Information

Table 111. Chiesi Description and Major Businesses

Table 112. Chiesi Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 113. Chiesi Product

Table 114. Chiesi Recent Development

Table 115. Cipla Corporation Information

Table 116. Cipla Description and Major Businesses

Table 117. Cipla Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 118. Cipla Product

Table 119. Cipla Recent Development

Table 120. Civitas/Alkermes Corporation Information

Table 121. Civitas/Alkermes Description and Major Businesses

Table 122. Civitas/Alkermes Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 123. Civitas/Alkermes Product

Table 124. Civitas/Alkermes Recent Development

Table 125. GlaxoSmithKline Corporation Information

Table 126. GlaxoSmithKline Description and Major Businesses

Table 127. GlaxoSmithKline Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 128. GlaxoSmithKline Product

Table 129. GlaxoSmithKline Recent Development

Table 130. Hovione Corporation Information

Table 131. Hovione Description and Major Businesses

Table 132. Hovione Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 133. Hovione Product

Table 134. Hovione Recent Development

Table 135. Mannkind Corporation Information

Table 136. Mannkind Description and Major Businesses

Table 137. Mannkind Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 138. Mannkind Product

Table 139. Mannkind Recent Development

Table 140. Mantecorp Corporation Information

Table 141. Mantecorp Description and Major Businesses

Table 142. Mantecorp Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 143. Mantecorp Product

Table 144. Mantecorp Recent Development

Table 145. Meda Corporation Information

Table 146. Meda Description and Major Businesses

Table 147. Meda Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 148. Meda Product

Table 149. Meda Recent Development

Table 150. MicroDose Therapeutx Corporation Information

Table 151. MicroDose Therapeutx Description and Major Businesses

Table 152. MicroDose Therapeutx Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 153. MicroDose Therapeutx Product

Table 154. MicroDose Therapeutx Recent Development

Table 155. Novartis Corporation Information

Table 156. Novartis Description and Major Businesses

Table 157. Novartis Devices for Inhaled Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 158. Novartis Product

Table 159. Novartis Recent Development

Table 160. Global Devices for Inhaled Medications Revenue Forecast by Region (2021-2026) (Million US$)

Table 161. Global Devices for Inhaled Medications Production Forecast by Regions (2021-2026) (K Units)

Table 162. Global Devices for Inhaled Medications Production Forecast by Type (2021-2026) (K Units)

Table 163. Global Devices for Inhaled Medications Revenue Forecast by Type (2021-2026) (Million US$)

Table 164. North America Devices for Inhaled Medications Consumption Forecast by Regions (2021-2026) (K Units)

Table 165. Europe Devices for Inhaled Medications Consumption Forecast by Regions (2021-2026) (K Units)

Table 166. Asia Pacific Devices for Inhaled Medications Consumption Forecast by Regions (2021-2026) (K Units)

Table 167. Latin America Devices for Inhaled Medications Consumption Forecast by Regions (2021-2026) (K Units)

Table 168. Middle East and Africa Devices for Inhaled Medications Consumption Forecast by Regions (2021-2026) (K Units)

Table 169. Devices for Inhaled Medications Distributors List

Table 170. Devices for Inhaled Medications Customers List

Table 171. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 172. Key Challenges

Table 173. Market Risks

Table 174. Research Programs/Design for This Report

Table 175. Key Data Information from Secondary Sources

Table 176. Key Data Information from Primary Sources

List of Fifures

Figure 1. Devices for Inhaled Medications Product Picture

Figure 2. Global Devices for Inhaled Medications Production Market Share by Type in 2020 & 2026

Figure 3. Dry Powder Inhalers Product Picture

Figure 4. Metered-Dose Inhalers Product Picture

Figure 5. Nebulizers Product Picture

Figure 6. Soft Mist Inhaler Product Picture

Figure 7. Global Devices for Inhaled Medications Consumption Market Share by Application in 2020 & 2026

Figure 8. Clinic

Figure 9. Hospital

Figure 10. Home

Figure 11. Devices for Inhaled Medications Report Years Considered

Figure 12. Global Devices for Inhaled Medications Revenue 2015-2026 (Million US$)

Figure 13. Global Devices for Inhaled Medications Production Capacity 2015-2026 (K Units)

Figure 14. Global Devices for Inhaled Medications Production 2015-2026 (K Units)

Figure 15. Global Devices for Inhaled Medications Market Share Scenario by Region in Percentage: 2020 Versus 2026

Figure 16. Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 17. Global Devices for Inhaled Medications Production Share by Manufacturers in 2015

Figure 18. The Top 10 and Top 5 Players Market Share by Devices for Inhaled Medications Revenue in 2019

Figure 19. Global Devices for Inhaled Medications Production Market Share by Region (2015-2020)

Figure 20. Devices for Inhaled Medications Production Growth Rate in North America (2015-2020) (K Units)

Figure 21. Devices for Inhaled Medications Revenue Growth Rate in North America (2015-2020) (US$ Million)

Figure 22. Devices for Inhaled Medications Production Growth Rate in Europe (2015-2020) (K Units)

Figure 23. Devices for Inhaled Medications Revenue Growth Rate in Europe (2015-2020) (US$ Million)

Figure 24. Devices for Inhaled Medications Production Growth Rate in China (2015-2020) (K Units)

Figure 25. Devices for Inhaled Medications Revenue Growth Rate in China (2015-2020) (US$ Million)

Figure 26. Devices for Inhaled Medications Production Growth Rate in Japan (2015-2020) (K Units)

Figure 27. Devices for Inhaled Medications Revenue Growth Rate in Japan (2015-2020) (US$ Million)

Figure 28. Global Devices for Inhaled Medications Consumption Market Share by Regions 2015-2020

Figure 29. North America Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 30. North America Devices for Inhaled Medications Consumption Market Share by Application in 2019

Figure 31. North America Devices for Inhaled Medications Consumption Market Share by Countries in 2019

Figure 32. U.S. Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 33. Canada Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 34. Europe Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 35. Europe Devices for Inhaled Medications Consumption Market Share by Application in 2019

Figure 36. Europe Devices for Inhaled Medications Consumption Market Share by Countries in 2019

Figure 37. Germany Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 38. France Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 39. U.K. Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 40. Italy Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 41. Russia Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 42. Asia Pacific Devices for Inhaled Medications Consumption and Growth Rate (K Units)

Figure 43. Asia Pacific Devices for Inhaled Medications Consumption Market Share by Application in 2019

Figure 44. Asia Pacific Devices for Inhaled Medications Consumption Market Share by Regions in 2019

Figure 45. China Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 46. Japan Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 47. South Korea Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 48. India Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 49. Australia Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 50. Taiwan Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 51. Indonesia Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 52. Thailand Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 53. Malaysia Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 54. Philippines Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 55. Vietnam Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 56. Latin America Devices for Inhaled Medications Consumption and Growth Rate (K Units)

Figure 57. Latin America Devices for Inhaled Medications Consumption Market Share by Application in 2019

Figure 58. Latin America Devices for Inhaled Medications Consumption Market Share by Countries in 2019

Figure 59. Mexico Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 60. Brazil Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 61. Argentina Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 62. Middle East and Africa Devices for Inhaled Medications Consumption and Growth Rate (K Units)

Figure 63. Middle East and Africa Devices for Inhaled Medications Consumption Market Share by Application in 2019

Figure 64. Middle East and Africa Devices for Inhaled Medications Consumption Market Share by Countries in 2019

Figure 65. Turkey Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 66. Saudi Arabia Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 67. U.A.E Devices for Inhaled Medications Consumption and Growth Rate (2015-2020) (K Units)

Figure 68. Global Devices for Inhaled Medications Production Market Share by Type (2015-2020)

Figure 69. Global Devices for Inhaled Medications Production Market Share by Type in 2019

Figure 70. Global Devices for Inhaled Medications Revenue Market Share by Type (2015-2020)

Figure 71. Global Devices for Inhaled Medications Revenue Market Share by Type in 2019

Figure 72. Global Devices for Inhaled Medications Production Market Share Forecast by Type (2021-2026)

Figure 73. Global Devices for Inhaled Medications Revenue Market Share Forecast by Type (2021-2026)

Figure 74. Global Devices for Inhaled Medications Market Share by Price Range (2015-2020)

Figure 75. Global Devices for Inhaled Medications Consumption Market Share by Application (2015-2020)

Figure 76. Global Devices for Inhaled Medications Value (Consumption) Market Share by Application (2015-2020)

Figure 77. Global Devices for Inhaled Medications Consumption Market Share Forecast by Application (2021-2026)

Figure 78. Global Devices for Inhaled Medications Revenue Forecast by Regions (2021-2026) (US$ Million)

Figure 79. Global Devices for Inhaled Medications Revenue Market Share Forecast by Regions ((2021-2026))

Figure 80. Global Devices for Inhaled Medications Production Forecast by Regions (2021-2026) (K Units)

Figure 81. North America Devices for Inhaled Medications Production Forecast (2021-2026) (K Units)

Figure 82. North America Devices for Inhaled Medications Revenue Forecast (2021-2026) (US$ Million)

Figure 83. Europe Devices for Inhaled Medications Production Forecast (2021-2026) (K Units)

Figure 84. Europe Devices for Inhaled Medications Revenue Forecast (2021-2026) (US$ Million)

Figure 85. China Devices for Inhaled Medications Production Forecast (2021-2026) (K Units)

Figure 86. China Devices for Inhaled Medications Revenue Forecast (2021-2026) (US$ Million)

Figure 87. Japan Devices for Inhaled Medications Production Forecast (2021-2026) (K Units)

Figure 88. Japan Devices for Inhaled Medications Revenue Forecast (2021-2026) (US$ Million)

Figure 89. Global Devices for Inhaled Medications Consumption Market Share Forecast by Region (2021-2026)

Figure 90. Devices for Inhaled Medications Value Chain

Figure 91. Channels of Distribution

Figure 92. Distributors Profiles

Figure 93. Porter's Five Forces Analysis

Figure 94. Bottom-up and Top-down Approaches for This Report

Figure 95. Data Triangulation

Figure 96. Key Executives Interviewed